BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28550173)

  • 1. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.
    Saiki H; Moulay G; Guenzel AJ; Liu W; Decklever TD; Classic KL; Pham L; Chen HH; Burnett JC; Russell SJ; Redfield MM
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H392-H407. PubMed ID: 28550173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular diastolic dysfunction and exercise intolerance in obese heart failure with preserved ejection fraction.
    Samuel TJ; Kitzman DW; Haykowsky MJ; Upadhya B; Brubaker P; Nelson MB; Hundley WG; Nelson MD
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1535-H1542. PubMed ID: 33577436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening.
    Sorop O; Heinonen I; van Kranenburg M; van de Wouw J; de Beer VJ; Nguyen ITN; Octavia Y; van Duin RWB; Stam K; van Geuns RJ; Wielopolski PA; Krestin GP; van den Meiracker AH; Verjans R; van Bilsen M; Danser AHJ; Paulus WJ; Cheng C; Linke WA; Joles JA; Verhaar MC; van der Velden J; Merkus D; Duncker DJ
    Cardiovasc Res; 2018 Jun; 114(7):954-964. PubMed ID: 29432575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction.
    Monma Y; Shindo T; Eguchi K; Kurosawa R; Kagaya Y; Ikumi Y; Ichijo S; Nakata T; Miyata S; Matsumoto A; Sato H; Miura M; Kanai H; Shimokawa H
    Cardiovasc Res; 2021 Apr; 117(5):1325-1338. PubMed ID: 32683442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.
    Matesic LE; Freeburg LA; Snyder LB; Duncan LA; Moore A; Perreault PE; Zellars KN; Goldsmith EC; Spinale FG
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H765-H774. PubMed ID: 32822210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
    Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy.
    Røe ÅT; Aronsen JM; Skårdal K; Hamdani N; Linke WA; Danielsen HE; Sejersted OM; Sjaastad I; Louch WE
    Cardiovasc Res; 2017 Aug; 113(10):1161-1172. PubMed ID: 28472418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wall stress determines systolic and diastolic function--Characteristics of heart failure.
    Alter P; Koczulla AR; Nell C; Figiel JH; Vogelmeier CF; Rominger MB
    Int J Cardiol; 2016 Jan; 202():685-93. PubMed ID: 26454537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction.
    Borlaug BA; Jaber WA; Ommen SR; Lam CS; Redfield MM; Nishimura RA
    Heart; 2011 Jun; 97(12):964-9. PubMed ID: 21478380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
    Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
    JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acute hypertension on left ventricular diastolic pressures in a canine model of left ventricular dysfunction with a preserved ejection fraction and elevated left ventricular filling pressures.
    Lavine SJ; Lavine JA
    J Am Soc Echocardiogr; 2006 Nov; 19(11):1350-8. PubMed ID: 17098138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction.
    Prasad A; Hastings JL; Shibata S; Popovic ZB; Arbab-Zadeh A; Bhella PS; Okazaki K; Fu Q; Berk M; Palmer D; Greenberg NL; Garcia MJ; Thomas JD; Levine BD
    Circ Heart Fail; 2010 Sep; 3(5):617-26. PubMed ID: 20682947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study.
    Santos-Gallego CG; Requena-Ibanez JA; San Antonio R; Garcia-Ropero A; Ishikawa K; Watanabe S; Picatoste B; Vargas-Delgado AP; Flores-Umanzor EJ; Sanz J; Fuster V; Badimon JJ
    JACC Cardiovasc Imaging; 2021 Feb; 14(2):393-407. PubMed ID: 33129742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited Impact of β-Adrenergic Receptor Activation on Left Ventricular Diastolic Function in Rat Models of Hypertensive Heart Disease.
    Bamaiyi AJ; Norton GR; Peterson V; Norman G; Mojiminiyi FB; Woodiwiss AJ
    J Cardiovasc Pharmacol; 2018 Nov; 72(5):242-251. PubMed ID: 30403389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.
    Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.